CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Arrowhead Research
ARWR
$4.02B
| $11.7M | 0.11% |
271,146
-50,000
| -16% | -$2.15M |
|
202
Becton Dickinson
BDX
$55.1B
| $11.6M | 0.11% |
51,260
-5
| -0% | -$1.14K |
|
|
BZUN
203
Baozun
BZUN
$207M
| $11.6M | 0.11% |
358,000
-160,000
| -31% | -$5.2M |
|
|
MNTA
204
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $11.5M | 0.11% |
219,575
-187,445
| -46% | -$9.84M |
|
205
Sherwin-Williams
SHW
$92.9B
| $11.5M | 0.11% |
49,524
-3,072
| -6% | -$713K |
|
206
Madrigal Pharmaceuticals
MDGL
$9.65B
| $11.2M | 0.11% |
94,584
-8,000
| -8% | -$950K |
|
207
Travelers Companies
TRV
$62B
| $11.2M | 0.11% |
103,563
+74,151
| +252% | +$8.02M |
|
|
ITCI
208
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11M | 0.1% |
430,000
-140,000
| -25% | -$3.59M |
|
209
Sempra
SRE
$52.9B
| $11M | 0.1% |
186,178
+115,618
| +164% | +$6.84M |
|
210
Personalis
PSNL
$465M
| $11M | 0.1% |
507,605
-16,145
| -3% | -$350K |
|
|
211
Kimberly-Clark
KMB
$43.1B
| $11M | 0.1% |
74,250
-189,997
| -72% | -$28.1M |
|
212
Mersana Therapeutics
MRSN
$34M
| $10.9M | 0.1% |
23,508
-322
| -1% | -$150K |
|
213
Amicus Therapeutics
FOLD
$2.46B
| $10.9M | 0.1% |
771,588
+30,000
| +4% | +$424K |
|
214
Estee Lauder
EL
$32.1B
| $10.8M | 0.1% |
49,343
-58,840
| -54% | -$12.8M |
|
|
GWPH
215
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $10.6M | 0.1% |
108,427
-11,535
| -10% | -$1.12M |
|
216
Bilibili
BILI
$9.25B
| $10.5M | 0.1% |
253,100
+71,600
| +39% | +$2.98M |
|
217
Blackrock
BLK
$170B
| $10.4M | 0.1% |
18,519
+8,324
| +82% | +$4.69M |
|
218
FibroGen
FGEN
$48.9M
| $10.4M | 0.1% |
10,122
+1,566
| +18% | +$1.61M |
|
219
Guardant Health
GH
$7.5B
| $10.3M | 0.1% |
92,338
+13,751
| +17% | +$1.54M |
|
220
Deere & Co
DE
$128B
| $10.3M | 0.1% |
46,509
-153
| -0.3% | -$33.9K |
|
221
argenx
ARGX
$45.9B
| $10.2M | 0.1% |
39,023
-20,884
| -35% | -$5.48M |
|
222
Tetra Tech
TTEK
$9.48B
| $10.2M | 0.1% |
535,700
+42,640
| +9% | +$814K |
|
223
Akamai
AKAM
$11.3B
| $10.2M | 0.1% |
92,434
+42,420
| +85% | +$4.69M |
|
224
Trex
TREX
$6.93B
| $10.2M | 0.1% |
142,629
+23,393
| +20% | +$1.67M |
|
|
BHVN
225
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.2M | 0.1% |
156,887
-15,912
| -9% | -$1.03M |
|